Ringpu Bio completes share repurchase and cancellation

Tianjin Ringpu Bio-Technology Co., Ltd. (SZSE:300119) announced the completion of the repurchase and cancellation of 1,093,200 restricted shares related to its 2022 restricted stock incentive plan, effective June 30, 2025. The cancelled shares represent 0.2347% of the company's total share capital before the repurchase and involved 176 incentive recipients. The repurchase and cancellation were triggered by the departure of 10 employees and the failure of the company to meet performance targets in 2024. The repurchase price was adjusted to CNY 8.40 per share. As a result of the cancellation, Ringpu Bio's total share capital decreased from 465,847,906 shares to 464,754,706 shares. The company plans to update its business registration to reflect the capital decrease.